• 1
    Timoney PJ. Equine influenza. Comp Immunol Microbiol Infect Dis 1996; 19:205211.
  • 2
    Guthrie AJ, Stevens KB, Boaman PP. The circumstances surrounding the outbreak and spread of equine influenza in South Africa. Rev Sci Tech 1999; 18:179185.
  • 3
    Powell DG, Watkins KL, Li PH, Shortridge KF. Outbreak of equine influenza among horses in Hong Kong during 1992. Vet Rec 1995; 136:531536.
  • 4
    Garner MG, Cowled B, East IJ, Maloney BJ, Kung NY. Evaluating the effectiveness of early vaccination in the control and eradication of equine influenza – A modeling approach. Prev Vet Med 2010; doi:10.1016/j.prevetmed.2010.02.007.
  • 5
    Van Maanen C, Cullinane A. Equine influenza virus: an update. Vet Q 2002; 2:7994.
  • 6
    Newton JR, Daly JM, Spencer L, Mumford JA. Description of the outbreak of equine influenza (H3N8) in the United Kingdom in 2003, during which recently vaccinated horses in Newmarket developed respiratory disease. Vet Rec 2006; 158:185192.
  • 7
    Mumford JA, Wood J. Establishing an acceptable threshold for equine influenza vaccines. Develop Biol Standard 1992; 79:137146.
  • 8
    Mumford JA, Wilson H, Hannant D, Jessett DM. Antigenicity and immunogenicity of equine influenza vaccines containing Carbomer adjuvant. Epidemiol Infect 1994; 112:421437.
  • 9
    Townsend HGG, Morley PS, Newton JR, Wood JLN, Haines DM, Mumford JA. Measuring serum antibody as a method of predicting infection and disease in horses during outbreaks of influenza; in: Equine Infectious Diseases VIII: Proceedings of the Eight International Conference on Equine Infectious Diseases 1999; 3337.
  • 10
    Newton JR, Townsend HGG, Wood JLN, Sinclair R, Hannant D, Mumford JA. Immunity to equine influenza: relationship of vaccine induced antibody in young thoroughbred racehorses to protection against field infection with influenza A/equine-2 viruses (H3N8). Equine Vet J 2000; 32:6574.
  • 11
    Mumford JA. Biology, epidemiology and vaccinology of equine influenza. Proceeding of the International Symposium, Budapest, 10-11 December 2001: 712.
  • 12
    Wood JLN. Equine Influenza: A Review of the History and Epidemiology and a Description of Recent Outbreak. MSc Dissertation, London School of Hygiene and Tropical Medicine, University of London, London, 1991.
  • 13
    Townsend HG, Penner SJ, Watts TC et al. Efficacy of a cold-adapted, intranasal, equine influenza vaccine: challenge trials. Equine Vet J 2001; 33:637643.
  • 14
    Lunn PD, Hussey S, Sebring R et al. Safety, efficacy, and immunogenicity of a modified-live equine influenza virus vaccine in ponies after induction of exercise-induced immunosuppression. J Am Vet Med Assoc 2001; 218:900906.
  • 15
    Toulemonde EC, Daly J, Sindle T, Guigal PM, Audonnet JC, Minke JM. Efficacy of a recombinant equine influenza vaccine against challenge with American lineage H3N8 influenza virus responsible for the 2003 outbreak in the United Kingdom. Vet Rec 2005; 156:367371.
  • 16
    Webster RG. Are equine 1 influenza viruses still present in horses? Equine Vet J 1993; 25:537538.
  • 17
    OIE Bulletin. Expert surveillance panel of equine influenza vaccines – conclusions and recommendations; Mill Hill, London (United Kingdom) 18th January, 2008, (2), 42–45.
  • 18
    OIE 2008. Manual of standards for diagnostic tests and vaccines, equine influenza, Chapter 2.5.7; 875877.
  • 19
    HRI, 2008. Horse racing Ireland fact book; Irish thoroughbred racing industry statistics. Year ended 31st December, 2008.
  • 20
    HSI, 2008. Horse sport Ireland. Profile of the Irish sports horse industry; 30th January 2008: 13.
  • 21
    Glass K, Wood LJ, Mumford JA, Jesset D, Grenfell BT. Modelling equine influenza 1: a stochastic model of within-yard epidemics. Epidemiol Infect 2002; 128:491502.
  • 22
    Davies JR, Grilli EA. Natural or vaccine induced antibody as a predictor of immunity in the face of natural challenge with influenza virus. Epidemiol Infect 1989; 102:325333.
  • 23
    Newton JR, Lakhani KH, Wood JL, Baker DJ. Risk factors for equine influenza serum antibody titres in young thoroughbred racehorses given an inactivated vaccine. Prev Vet Med 2000; 46:129141.
  • 24
    Van Oirschot JT, Bruin G, Boer-Luytze E, Smolders G. Maternal antibodies against equine influenza virus in foals and their interference with vaccination. J Vet Med 1991; 38:391396.
  • 25
    Van Maanen C, Bruin G, De Boer-Luijtze E, Smolders G, De-Boer GF. Interference of maternal antibodies with the immune response of foals after vaccination against equine influenza. Vet Q 1992; 14:1317.
  • 26
    Cullinane A, Weld J, Osborne M, Nelly M, McBride C. Field studies on equine influenza vaccination regimes in Thoroughbred foals and yearlings. Vet J 2001; 161:174185.
  • 27
    Minke JM, Toulemonde EC, Dinic S, Cozette V, Cullinane A, Audonnet JC. Effective priming of foals born to immune dams against influenza by Canarypox-Vectored Recombinant Influenza H3N8 Vaccine. J Comp Path 2007; 137:S76S80.
  • 28
    Wilson WD, Mihalyi JE, Hussey S, Lunn DP. Passive transfer of maternal immunoglobulin isotype antibodies against tetanus and influenza and their effect on the response of foals to vaccination. Equine Vet J 2001; 33:644650.
  • 29
    Folsom RW, Littlefield-Chabaud MA, French DD, Pourciau SS, Mistric L, Horohov DW. Exercise alters the immune response to equine influenza virus and increases susceptibility to infection. Equine Vet J 2001; 33:664669.
  • 30
    Hannant D, Mumford JA, Jesset DM. Duration of circulating antibody and immunity following infection with equine influenza virus. Vet Rec 1988; 122:125128.
  • 31
    Newton JR, Verheyen K, Wood JLN, Yates PJ, Mumford JA. Equine influenza in the United Kingdom in 1998. Vet Rec 1999; 145:449452.
  • 32
    Daly JM, Yates PJ, Newton RJ et al. Evidence supporting the inclusion of strains from each of the two co-circulating lineages of H3N8 equine influenza viruses in vaccines. Vaccine 2004; 22:41014109.